annual meeting program - American Society of Clinical Oncology

Saturday, June 5, 2010
Brd. 8 Surgeon influence on patient appraisal of ASCO breast cancer quality
indicators. (Abstract #6016)
S. T. Hawley, A. S. Hamilton, J. Graff, S. J. Katz
Brd. 9 The impact of audit and feedback on nodal harvest in colorectal cancer
(CRC). (Abstract #6017)
G. A. Porter, R. Urquhart, J. Bu, P. Johnson, E. Grunfeld
Brd. 10 Quality of care in non-small cell lung cancer (NSCLC): Findings from the
Florida Initiative for Quality Cancer Care (FIQCC). (Abstract #6018)
T. Tanvetyanon, M. Corman, W. J. Fulp, J. Lee, P. B. Jacobsen, FIQCC
Consortium Members
Brd. 11 Diagnostic imaging and biopsy use among elderly medicare beneficiaries
with hepatocellular carcinoma: Evaluating community guideline adherence.
(Abstract #6019)
N. N. Massarweh, J. O. Park, R. S. Yeung, J. Bruix, R. B. Etzioni, R. G. Symons,
L. Baldwin, D. R. Flum
Brd. 12 Scientific evidence underlying National Comprehensive Cancer Network
Clinical Practice Guidelines. (Abstract #6020)
T. K.Poonacha, R. S. Go
Brd. 13 End-of-life care for elderly patients with advanced lung cancer in the United
States and Ontario. (Abstract #6021)
K. Yabroff, J. Warren, L. C. Barbera, K. Bremner, J. Hoch, M. Barrett, J. Luo,
M. Krahn
Brd. 14 Impact of care at NCI-designated Comprehensive Cancer Centers (NCICCCs)
on racial differences in prostate cancer-specific survival. (Abstract #6022)
C. Sun, S. Kurian, G. T. Washington, K. Nielsen-Menicucci, L. E. Crocitto,
T. G. Wilson, L. Laddaran, W. Landier, S. Smith, S. Bhatia
Brd. 15 Trends in prostatectomy: Centralization, robotics, and access to care.
(Abstract #6023)
K. B. Stitzenberg, Y. Wong, M. E. Nielsen, R. Uzzo
Brd. 16 PSA surveillance in men with localized prostate cancer. (Abstract #6024)
D. N. Yeboa, K. Liao, T. Guzzo, N. B. Haas, J. P. Christodouleas, N. Vapiwala,
R. Sunderland, N. Mitra, K. Armstrong, J. E. Bekelman
Brd. 17 Restoration of medical oncology services at Charity Hospital in New Orleans
after Hurricane Katrina: A 2-year experience of the Louisiana State University
Health Sciences Center (LSUHSC). (Abstract #6025)
B. C. Boulmay, R. E. Harmon, T. L. Lin, J. T. Cole
Brd. 18 Appropriateness of cardiovascular (CV) care in cancer survivors (CS).
(Abstract #6026)
W. Y. Cheung, M. L. McBride, R. Levin, S. Setoguchi
Brd. 19 Estimation of the U.S. rate of neutropenic complications for cancer hospital
discharges. (Abstract #6027)
M. Dickson, C. M. Kozma, R. Barron, V. M. Chia, J. C. Legg, J. Malin
Brd. 20 Reporting of serious toxicities of targeted cancer drugs in published reports
of randomized phase III clinical trials (RCTs). (Abstract #6028)
B. Seruga, L. Sterling, L. Wang, I. Tannock
Brd. 21 A compendium of unpublished phase III clinical trials in oncology:
Characteristics and impact on clinical practice. (Abstract #6029)
V. C. Tam, I. Tannock, J. Rauw, M. K. Krzyzanowska
Brd. 22 The assessment of cost and other barriers to patient clinical trial
participation in the community setting. (Abstract #6030)
D. Weckstein, C. Thomas, I. F. Emery, B. F. Shea, A. Fleury, M. White, E. Chase,
S. Frazier, C. Robinson, C. Pilar
125
SATURDAY